These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24488880)

  • 41. Structure, function and regulation of p63 and p73.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
    Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p63 and p73, members of the p53 gene family, transactivate PKCdelta.
    Ponassi R; Terrinoni A; Chikh A; Rufini A; Lena AM; Sayan BS; Melino G; Candi E
    Biochem Pharmacol; 2006 Nov; 72(11):1417-22. PubMed ID: 16959223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p73 and p63 regulate the expression of fibroblast growth factor receptor 3.
    Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
    Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
    Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
    Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53/p63/p73 in the epidermis in health and disease.
    Botchkarev VA; Flores ER
    Cold Spring Harb Perspect Med; 2014 Aug; 4(8):. PubMed ID: 25085956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status.
    Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p73: in silico evidence for a putative third promoter region.
    Sayan AE; Rossi M; Melino G; Knight RA
    Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional regulation of p73 and p63: development and cancer.
    Melino G; Lu X; Gasco M; Crook T; Knight RA
    Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
    Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
    Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 Family members p63 and p73 are SAM domain-containing proteins.
    Thanos CD; Bowie JU
    Protein Sci; 1999 Aug; 8(8):1708-10. PubMed ID: 10452616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p73 isoforms meet evolution of metastasis.
    Logotheti S; Pavlopoulou A; Marquardt S; Takan I; Georgakilas AG; Stiewe T
    Cancer Metastasis Rev; 2022 Dec; 41(4):853-869. PubMed ID: 35948758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
    Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
    Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
    Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I
    Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unifying the p73 knockout phenotypes: TAp73 orchestrates multiciliogenesis.
    Napoli M; Flores ER
    Genes Dev; 2016 Jun; 30(11):1253-4. PubMed ID: 27298333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
    Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
    Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p73: From the p53 shadow to a major pharmacological target in anticancer therapy.
    Ramos H; Raimundo L; Saraiva L
    Pharmacol Res; 2020 Dec; 162():105245. PubMed ID: 33069756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.